Crescent Biopharma (CBIO)'s 30-day implied volatility (IV30) was 79.7% at the close on November 3, 2026, down from 84.3% the day before, against a 52-week range of 48.3% to 94.3%. Its 20-day historical volatility was 92.9%.
Data as of November 3, 2026.